Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool (Q34441092)

2 August 2017

title

Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool (English)

1 reference

malignant pleural mesothelioma

2 August 2017

1 reference

1 reference

Harvey I Pass

12

0 references

author name string

Rachel M Ostroff

1

1 reference

2 August 2017

Michael R Mehan

2

1 reference

2 August 2017

Alex Stewart

3

1 reference

2 August 2017

Deborah Ayers

4

1 reference

2 August 2017

Edward N Brody

5

1 reference

2 August 2017

Stephen A Williams

6

1 reference

2 August 2017

Stephen Levin

7

1 reference

2 August 2017

Brad Black

8

1 reference

2 August 2017

Michael Harbut

9

1 reference

2 August 2017

Michele Carbone

10

1 reference

2 August 2017

Chandra Goparaju

11

1 reference

2 August 2017

language of work or name

English

0 references

publication date

3 October 2012

1 reference

2 August 2017

1 reference

2 August 2017

volume

7

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

e46091

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

copyright license

start time

3 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Erionite exposure in North Dakota and Turkish villages with mesothelioma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Malignant mesothelioma: facts, myths, and hypotheses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Aptamer-based multiplexed proteomic technology for biomarker discovery

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Expanding the chemistry of DNA for in vitro selection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Current status of screening for malignant pleural mesothelioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Serum and pleural fluid biomarkers for mesothelioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Structural elements of kallistatin required for inhibition of angiogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Use of death certificates in epidemiological studies, including occupational hazards: variations in discordance of different asbestos-associated diseases on best evidence ascertainment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Inflammation-based prognostic indices in malignant pleural mesothelioma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3463527

Asbestos exposure, pleural mesothelioma, and serum osteopontin levels

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23056237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0046091

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference